A Milwaukee-area medical expert is weighing in on a new study examining a possible link between GLP-1 weight loss drugs and cancer risk. The expert says the findings require careful interpretation and urges patients to discuss benefits and risks with their doctors before making changes.
Breakdown
- GLP-1 drugs like Ozempic do not reduce cancer risk as previously thought 13s
- Study of 94,000 diabetics found no evidence GLP-1s reduce or cause cancer 18s
- Women with fibroids have an 81% higher relative risk of heart disease 1m 10s
- Children with smartphones at age 12 face higher risks of depression, obesity, and sleep issues 2m 5s
- Parents should monitor smartphone use and discuss mental health with children 2m 41s